跳至主要内容
临床试验/IRCT201008174582N1
IRCT201008174582N1已完成2 期

The assessment of the effect of injection of Botulinum toxin A (Transurethral method) on Benign Prostate Hyperplasia refractory to routine medical treatment in poor surgical candidates

Vice chancellor for research of Guilan University of Medical Sciences0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50 years 至 149 years(—)
性别
Male

入选标准

  • male patients older than 50 years, patients with BPH refractory to medical therapy and not suitable for surgery, IPSS (International Prostatic Symptom Score) =8. Exclusion criteria: active UTI, previous history of prostate surgery, prostate cancer, acute prostatitis, simultaneous use of drugs such as: Amino glycosides, Cholinergics, Anticholinergics, Androgens, Estrogen, Steroids, history of allergy to BoNT-A, neurologic disease like Parkinson, Myastenia Gravis, Multiple Sclerosis, history of allergy to BoNT.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research of Guilan University of Medical Sciences

相似试验